COVID Medicine

After Zydus Cadila and Jubilant Life, Dr. Reddy's Signs Licensing Agreement with Gilead Sciences for Remdesivir

This deal will be valid in 127 countries including India. Gilead Sciences has signed a non-exclusive licensing agreement with Zydus Cadila and Jubilant Life as well. This would be third such deal for Indian market.